Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) LONDON, ON - TheNewswire – November 16 , 2021 -- Sernova Corp . (TSXV:SVA)(FSE/XETRA:PSH)(OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced that Dr. P...
(TheNewswire) Information Session Webinar on Sernova’s Conformal Coating Immune Protection Technology with Dr. Toleikis and International Expert, Dr. Tomei Now Available on Sernova’s Website L ondon, Ontario - TheNewswire - October 1, 2021 - Serno...
(TheNewswire) Integrated Advisory and Investor Relations Program to Focus on Elevating Company’s Visibility in US Capital Markets Ahead of Projected Corporate Milestones LONDON, ONTARIO - TheNewswire - September 29, 2021 - Sernova Corp. (TSXV:SVA) (OTC:S...
(TheNewswire) Collaboration to build on positive Cell Pouch T1D Clinical Outcomes and preclinical success in Global Pharmaceutical Collaborations to develop regenerative medicine therapeutic cures without life-long immunosuppression medications across multiple diseases ...
(TheNewswire) L ondon , ON - TheNewswire - August 9 , 2021 - Sernova Corp . (TSXV:SVA) (FSE/XETRA:PSH) (OTC:SEOVF), a leading clinical-stage company focused on regenerative medicine therapeutics, today announced t...
Click here to read the previous top Canadian pharma stocks article. The Canadian pharmaceutical industry has positioned itself firmly on the global map thanks to advances in biotechnology and investments in medical research and development. The life science s...
(TheNewswire) LONDON, ONTARIO - TheNewswire - July 5, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH) , a leading clinical-stage regenerative medicine therapeutics company, held its annual shareholder meeting (the “Meeting”) via the virtua...
(TheNewswire) 25-Year Industry Veteran in Clinical/Regulatory Therapeutics Development Joins Sernova’s Executive Team L ondon, Ontario - TheNewswire - June 30, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH ), a leadi...
(TheNewswire) First Patient Successfully Completes Clinical Trial and Shares Study Experiences and Impact LONDON, ONTARIO - TheNewswire - June 28, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE/XETRA:PSH), a leading ...
(TheNewswire) Multiple patients with sustained clinical benefit, including positive fasting serum C-peptide (a biomarker of insulin produced by Sernova’s Cell Pouch islets) detected in their bloodstream LONDON, ONTARIO – TheNewswire - June...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...